Join Us for Epi One’s Final Investment Webinar – A Conversation with CEO Michael Marquardt and Chief Scientist & Founder Dr. Fang

Nov 19, 2024

As our StartEngine campaign enters its final weeks, we’re excited to invite you to a special webinar event on November 26th at 4:30 PM Eastern Time. This session offers a unique opportunity to engage directly with our CEO, Michael Marquardt, and our Chief Scientist & Founder, Dr. Fang, before our campaign closes. 

Why This Webinar Matters

Early cancer detection can mean the difference between life and death. While this fact drives our work every day at Epi One, it also underscores why this webinar is so important. We’ll share how our technology aims to detect cancer earlier, when treatment options are most effective and outcomes are better.

Our approach to cancer detection combines epigenetics with practical diagnostic tools – but what does this mean for patients, doctors, and the future of cancer screening? During this webinar, Michael will break down the science behind our work and explain how we’re working to make cancer screening more accessible and affordable.

What to Expect

This isn’t just another corporate presentation. We’ve structured this session to be interactive and informative, focusing on the questions that matter most to our community of supporters and potential investors. Here’s what we’ll cover:

  1. Technical Innovation: A clear explanation of our detection method and how it works
  2. Market Impact: Understanding where we fit in the current healthcare landscape
  3. Development Progress: Our timeline, achievements, and next steps
  4. Open Q&A: Your chance to ask questions directly to our CEO

Meet Our Speakers

Michael Marquardt brings unique insight to this conversation. As the former Board Chair of the American Cancer Society and our current CEO, he bridges the gap between understanding cancer’s impact on society and leading technological innovation in cancer detection. With his background in chemistry and extensive experience in both healthcare and technology sectors, Michael offers a comprehensive perspective on our work and its potential impact.

Dr. Fang “Sophia” Fang brings extensive expertise in genomics and cancer biology as Epi One’s Co-Founder and Chief Scientific Officer. With both an MD and PhD, her research at Memorial Sloan Kettering Cancer Center focused on identifying cancer biomarkers and understanding tumor progression. Dr. Fang’s dual degrees from Harbin Medical University and Iowa State University combine clinical knowledge with advanced research capabilities, enabling her to bridge the gap between laboratory innovation and practical medical applications in Epi One’s early detection technology.

Why Attend?

Whether you’re a current investor, considering an investment, or simply interested in cancer detection technology, this webinar offers valuable insights. You’ll learn:

  • How our technology differs from current cancer screening methods
  • The specific challenges we’re addressing in cancer detection
  • Our progress and key milestones
  • Where we’re headed and how we plan to get there

Making an Informed Decision

With our StartEngine campaign closing soon, this webinar serves as your final opportunity to gather the information you need to make an informed investment decision. We believe in transparency and want to ensure you have all the facts about our work, our goals, and our vision for the future.

Join Us

Don’t miss this opportunity to be part of our journey to improve cancer detection. Register now for our webinar on November 26th at 4:30 PM Eastern Time. Bring your questions, your curiosity, and your passion for advancing healthcare.

Register here: https://dnagency.lpages.co/epi-one-final-investor-webinar/

This Reg CF offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

MORE NEWS

Transforming Early Cancer Detection: Latest Webinar Highlights

At Epi One, we're on a mission to revolutionize how cancer is detected and diagnosed. During our recent ...

Epi One: Top Reasons to Invest Today

7 Reasons to Invest in Epi One: Transforming Cancer Detection Imagine a world where a simple test could ...

Webinar Recap: Transforming Lives Through Early Cancer Detection

At Epi One, we're on a mission to change the landscape of cancer detection. Our recent webinar, led ...

Market Opportunity with Epi One

Market Opportunity with Epi One We believe Epi One is at the vanguard of the rapidly evolving cancer ...

$1 Million Raised from Equity Crowdfunding

We are incredibly excited and humbled to announce that Epi One has now surpassed the $1 million mark ...

Scientific Breakthrough in the Lab

We are delighted to report that recent experiments have enabled us to identify biomarkers for lung, pancreatic, stomach ...

StartEngine Campaign Surpasses $500,000

We are thrilled to announce that following the launch of our equity crowdfunding campaign on StartEngine on May ...
cancer diagnosis tools

Equity Crowdfunding Campaign for Cancer Diagnosis Tools

We are excited to announce the launch of our equity crowdfunding campaign on StartEngine. This campaign offers individuals ...
cancer diagnosis technology

Cancer Diagnosis Angel Investment Tops $1 million

As revealed on CityBiz this week, we are delighted to confirm that ahead of our upcoming launch on ...
early detection of cancer symptoms

Early Detection of Cancer Symptoms

We have discovered a way to make early detection of cancer symptoms accurate, affordable and a reality for ...
Scroll to Top